Novel molecular markers for acute myeloid leukaemia disease activity

被引:0
|
作者
Sittig, E. [1 ,2 ]
Kauko, O. [1 ,2 ,3 ,4 ]
Salmenniemi, U. [5 ]
Laiho, A. [1 ,2 ]
Kairisto, V. [6 ]
Johansson, J. [5 ]
Itala-Remes, M. [5 ]
Westermarck, J. [1 ,2 ,3 ]
机构
[1] Univ Turku, Turku, Finland
[2] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland
[3] Abo Akad Univ, Dept Pathol, Turku, Finland
[4] Abo Akad Univ, Turku Doctoral Programme Biomed Sci, Turku, Finland
[5] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland
[6] Turku Univ Hosp, Cent Lab, FIN-20520 Turku, Finland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3612
引用
收藏
页码:S840 / S840
页数:1
相关论文
共 50 条
  • [21] Acute myeloid leukaemia
    Asim Khwaja
    Magnus Bjorkholm
    Rosemary E. Gale
    Ross L. Levine
    Craig T. Jordan
    Gerhard Ehninger
    Clara D. Bloomfield
    Eli Estey
    Alan Burnett
    Jan J. Cornelissen
    David A. Scheinberg
    Didier Bouscary
    David C. Linch
    Nature Reviews Disease Primers, 2
  • [22] Acute myeloid leukaemia
    Focosi, Daniele
    LANCET, 2007, 369 (9559): : 367 - 367
  • [23] Acute myeloid leukaemia
    Khwaja, Asim
    Bjorkholm, Magnus
    Gale, Rosemary E.
    Levine, Ross L.
    Jordan, Craig T.
    Ehninger, Gerhard
    Bloomfield, Clara D.
    Estey, Eli
    Burnett, Alan
    Cornelissen, Jan J.
    Scheinberg, David A.
    Bouscary, Didier
    Linch, David C.
    NATURE REVIEWS DISEASE PRIMERS, 2016, 2
  • [24] Acute myeloid leukaemia
    Stretton, Owen
    LANCET HAEMATOLOGY, 2022, 9 (08): : E557 - E557
  • [25] Measurable residual disease testing in acute myeloid leukaemia
    Hourigan, C. S.
    Gale, R. P.
    Gormley, N. J.
    Ossenkoppele, G. J.
    Walter, R. B.
    LEUKEMIA, 2017, 31 (07) : 1482 - 1490
  • [26] Acute myeloid leukaemia
    Short, Nicholas J.
    Rytting, Michael E.
    Cortes, Jorge E.
    LANCET, 2018, 392 (10147): : 593 - 606
  • [27] Acute Myeloid Leukaemia
    Huntly, Brian J. P.
    HEMATOLOGIE, 2021, 27 (04): : 160 - 161
  • [28] Acute myeloid leukaemia
    Burnett, A.
    Mills, K. I.
    EJC SUPPLEMENTS, 2007, 5 (04): : 53 - 53
  • [30] Minimal residual disease evaluation in acute myeloid leukaemia
    Yin, JAL
    Grimwade, D
    LANCET, 2002, 360 (9327): : 160 - 162